What is Ionis Pharmaceuticals (IONS)?
Ionis Pharmaceuticals is a biotechnology company specializing in the discovery and development of RNA-targeted therapeutics. The company employs antisense technology to design molecules that modulate gene expression by binding to specific RNA sequences. Ionis focuses on developing treatments for a range of diseases, including neurological, cardiovascular, metabolic, and rare genetic disorders. Its platform enables the creation of drugs that can selectively inhibit or modify the production of disease-causing proteins. Ionis collaborates with pharmaceutical companies to advance its pipeline and bring therapies to market. The company’s approach represents a novel modality in drug development, offering potential advantages in specificity and mechanism of action. Ionis integrates research in molecular biology, chemistry, and genomics to innovate in the field of precision medicine. Its work contributes to expanding therapeutic options for conditions with unmet medical needs.
Ionis Pharmaceuticals Stock Price Today: Live Overview
The price today is shaped by market action, with Ionis Pharmaceuticals trading at $71.44. The intraday range lies between $70.24 and $73.49, showing a daily change of 0%.
FAQ: Ionis Pharmaceuticals (IONS)
What is the current price of IONS stock?
Ionis Pharmaceuticals' last traded price is $71.44.
Does IONS pay dividends?
Ionis Pharmaceuticals pays dividends via cash distributions (if applicable).
Does IONS have a formal corporate presence or regional headquarters in the UAE?
Ionis Pharmaceuticals operates via partners and distributors in the UAE and does not have an official regional office or subsidiary.
What is IONS best known for?
Ionis Pharmaceuticals is most famous for its RNA-targeted drug discovery and development.
What assets are typically shown together with IONS?
Commonly shown alongside IONS: Stoke Therapeutics, Inc., Madrigal Pharmaceuticals, Inc., Viking Therapeutics, Inc.
Latest shares articles



